Ads
related to: what is factor x deficiency treatment- Prophylaxis Information
Keep Your Patients With
Hemophilia A Protected From Bleeds.
- Dosing And Administration
Information For HCPs On Dosing,
Reconstitution and Administration.
- Dosing & Administration
Information on Dosing,
Reconstitution and Administration.
- Pharmacology Information
Find More Information About
a Treatment Option.
- Cost And Coverage
Information On Financial Programs &
Aid For Patients With Hemophilia A.
- Perioperative Safety
Learn About Phase 3 Pivotal
Trial Results Showing Efficacy.
- Prophylaxis Information
Search results
Results From The WOW.Com Content Network
Factor X deficiency (X as Roman numeral ten) is a bleeding disorder characterized by a lack in the production of factor X (FX), an enzyme protein that causes blood to clot in the coagulation cascade. Produced in the liver FX when activated cleaves prothrombin to generate thrombin in the intrinsic pathway of coagulation.
Inborn deficiency of factor X is very rare (1:1,000,000), and may present with epistaxis (nosebleeds), hemarthrosis (bleeding into joints) and gastrointestinal blood loss. . Apart from congenital deficiency, low factor X levels may occur occasionally in a number of disease stat
Scott syndrome is a rare congenital bleeding disorder that is due to a defect in a platelet mechanism required for blood coagulation. [1]Normally when a vascular injury occurs (i.e., a cut, scrape or other injury that causes bleeding), platelets are activated and phosphatidylserine (PS) in the inner leaflet of the platelet membrane is transported to the outer leaflet of the platelet membrane ...
Hypoprothrombinemia can be the result of a genetic defect, may be acquired as the result of another disease process, or may be an adverse effect of medication.For example, 5-10% of patients with systemic lupus erythematosus exhibit acquired hypoprothrombinemia due to the presence of autoantibodies which bind to prothrombin and remove it from the bloodstream (lupus anticoagulant ...
Haemophilia C (also known as plasma thromboplastin antecedent (PTA) deficiency or Rosenthal syndrome) is a mild form of haemophilia affecting both sexes, due to factor XI deficiency. [4] It predominantly occurs in Ashkenazi Jews. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B.
A 2022 statement from the World Health Organization (WHO), defines the term this way: “Disease X is [used] to indicate an unknown pathogen that could cause a serious international epidemic.”
Ads
related to: what is factor x deficiency treatment